Stack was nominated for this interview through The Scientists Peer Profile Program submissions.What inspired you to research study ovarian cancer?When I began studying ovarian cancer as a postdoctoral scientist in the early 1990s, it was an understudied illness. One in 87 ladies establishes ovarian cancer throughout her life time, and the survival rate of those who have ovarian cancer with metastatic illness has not increased much over the previous 30 to 40 years.1 The reality that ovarian cancer is such a pressing clinical issue motivates us to study it. What did you focus on when you initially started studying ovarian cancer?In the early days of my laboratory, we looked at ovarian cancer from a cell point of view. Another important location would be to comprehend cancer mutational processes in more varied populations considering that most of what scientists know about cancer comes from information collected in individuals of European ancestry. Ovarian cancer stats: How common is ovarian cancer.
One in 87 women establishes ovarian cancer during her lifetime, and the survival rate of those who have ovarian cancer with metastatic disease has not increased much over the previous 30 to 40 years.1 The fact that ovarian cancer is such a pushing clinical problem encourages us to study it. Another essential area would be to comprehend cancer mutational processes in more varied populations considering that most of what researchers understand about cancer comes from data collected in people of European origins. Ovarian cancer statistics: How common is ovarian cancer.
